Han, Chang-Woo
(Dept. of Internal Medicine, School of Korean Medicine, Pu-San National University)
Joo, Myung-Soo (Division of Applied Medicine, School of Korean Medicine, Pu-San National University) Lee, Jang-Hoon (Dept. of Internal Medicine, College of Korean Medicine, Kyung-Hee University) |
1 | Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol 2008;119(2):291-8. DOI ScienceOn |
2 | Kang DG, Yun YG, Ryoo JH, Lee HS. Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 2002;30(1):87-93. DOI ScienceOn |
3 | Liu G, Guan GJ, Qi TG, Fu YQ, Li XG, Sun Y, et al. [Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism]. Zhong Xi Yi Jie He Xue Bao 2005;3(6):459-62. DOI ScienceOn |
4 | Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009;32(2):220-4. DOI ScienceOn |
5 | Okuno I, Uchida K, Kadowaki M, Akahori A. Choleretic effect of Artemisia capillaris extract in rats. Jpn J Pharmacol 1981;31(5):835-8. DOI |
6 | Hong JH, Hwang EY, Kim HJ, Jeong YJ, Lee IS. Artemisia capillaris inhibits lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet. J Med Food 2009; 12(4):736-45. DOI ScienceOn |
7 | Pan J, Liu G, Liu H, Qiu Z, Chen L. [Effects of artemisia capillaris on blood glucose and lipid in mice]. Zhong Yao Cai 1998;21(8):408-11. |
8 | Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011;15(38):1-110. |
9 | Han CW, Lee JH. Effects of KHchunggan-tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Oriental Med 2011;32(1):109-20. |
10 | Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82(967): 315-22. DOI ScienceOn |
11 | Wu JN. An illustrated Chinese materia medica. New York: Oxford University Press; 2005, p. 59, 111, 225, 235, 403, 565. |
12 | Hong X, Tang H, Wu L, Li L. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J Pharm Pharmacol 2006;58(10):1391-8. DOI ScienceOn |
13 | Han CW, Kang ES, Ham SA, Woo HJ, Lee JH, Seo HG. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharm Biol 2012;50(10):1281-8. DOI ScienceOn |
14 | Lin HR. Triterpenes from Alisma orientalis act as farnesoid X receptor agonists. Bioorg Med Chem Lett 2012;22(14):4787-92. DOI ScienceOn |
15 | Li HB, Fang KY, Lu CT, Li XE. [Study on lipid-regulating function for the extracts and their prescriptions from Semen Cassiae and fructus crataegi]. Zhong yao cai 2007;30(5): 573-5. |
16 | Niu C, Chen C, Chen L, Cheng K, Yeh C, Cheng J. Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPARalpha in liver of mice fed high-fat diet. Horm Metab Res 2011;43(9):625-30. DOI ScienceOn |
17 | Wu HT, He XJ, Hong YK, Ma T, Xu YP, Li HH. Chemical characterization of Lycium barbarum polysaccharides and its inhibition against liver oxidative injury of high-fat mice. Int J Biol Macromol 2010;46(5):540-3. DOI ScienceOn |
18 | Zhao R, Li Q, Xiao B. Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats. Yakugaku Zasshi 2005;125(12):981-8. DOI ScienceOn |
19 | Shin JH, Kang MJ, Yang SM, Lee SJ, sung NJ. Effects of namhae specialized crops water extract on lipid metabolism in rats fed a cholesterol diet. Korean J Food Cookery Sci 2011;27(5):599-610. DOI |
20 | Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004;76(2):137-49. DOI ScienceOn |
21 | Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005;11(7):BR228-34. |
22 | Zhang ZP, You TT, Zou LY, Wu T, Wu Y, Cui L. [Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2008;28(7):1109-13. |
23 | Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21(1Pt1): 138-43. DOI |
24 | Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med 2012;124(1):21-30. DOI ScienceOn |
25 | Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-74. DOI ScienceOn |